8
S. Raghavan, A. Ravi / Tetrahedron xxx (2017) 1e10
colorless oil (93 mg, 0.176 mmol) in 93% yield which was used
1H), 5.47e5.36 (m, 2H), 4.67 (d, J ¼ 6.9 Hz, 1H), 4.61 (d, J ¼ 6.9 Hz,
1H), 4.26e4.16 (m, 3H), 4.12e4.06 (m, 2H), 3.67 (dd, J ¼ 11.4, 2.9 Hz,
1H), 3.61e3.56 (m, 2H), 3.41 (dd, J ¼ 8.2, 3.1 Hz, 1H), 3.36 (s, 3H),
2.36e2.26 (m, 1H), 2.21e2.13 (m, 2H), 1.94e1.87 (m, 1H), 1.70 (s,
3H), 1.45 (s, 3H), 1.29 (s, 3H), 1.09 (d, J ¼ 6.3 Hz, 3H), 1.00 (d,
J ¼ 6.9 Hz, 3H), 0.91 (s, 9H), 0.06 (s, 3H), 0.02 (s, 3H); 13C NMR
without any further purification. TLC: Rf ¼ 0.4 (ethyl acetate:hex-
20
anes, 4:6); [
a
]
D: þ0.7ꢁ (c 0.9, CHCl3); IR (neat): 3448, 2931, 2854,
1728, 1427, 1384, 1108 cm-1; 1H NMR (500 MHz, CDCl3):
d 5.64 (t,
J ¼ 5.8 Hz, 1H), 5.61e5.35 (m, 2H), 4.67 (d, J ¼ 6.9 Hz, 1H), 4.60 (d,
J ¼ 6.9 Hz, 1H), 4.26 (d, J ¼ 5.8 Hz, 2H), 4.14e4.10 (m, 2H), 4.02 (dd,
J ¼ 8.7, 5.2 Hz, 1H), 3.73e3.63 (m, 2H), 3.62e3.56 (m, 1H), 3.42 (dd,
J ¼ 8.9, 5.2 Hz, 1H), 3.36 (s, 3H), 2.59 (d, J ¼ 3.2 Hz, 1OH), 2.34e2.25
(m, 1H), 2.21e2.11 (m, 2H), 2.20e1.93 (m, 1H), 1.65 (s, 3H), 1.50 (s,
3H), 1.32 (s, 3H), 1.09 (d, J ¼ 6.3 Hz, 3H), 1.01 (d, J ¼ 6.9 Hz, 3H), 0.90
(125 MHz, CDCl3):
d 139.0, 135.2, 127.7, 124.4, 108.1, 95.2, 79.4, 77.0,
76.7, 75.5, 69.0, 65.3, 58.5, 55.3, 42.3, 36.8, 33.2, 28.3, 26.5, 25.9,
18.3, 17.0, 15.8, 13.8, ꢀ4.8; MS (ESI): 551 [MþNa]þ; HRMS (ESI): m/z
Calcd. for C28H52O7SiNa: 551.3375, found 551.3384.
(s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3):
d 135.2, 134.2, 128.2,
127.6, 108.7, 95.1, 78.6, 77.4, 76.5, 75.4, 70.9, 66.2, 60.0, 55.4, 42.2,
36.7, 33.8, 28.2, 26.3, 26.0, 18.3, 17.0, 15.8, 12.9, ꢀ5.1, ꢀ5.2; MS (ESI):
551 [MþNa]þ; HRMS (ESI): m/z Calcd. for C28H52O7SiNa: 551.3375,
found 551.3382.
4.1.20. (R,E)-4-((tert-Butyldimethylsilyl)oxy)-4-((3aR,4R,7S,7aR)-7-
((4R,5S,E)-5-(methoxymethoxy)-4-methylhex-2-en-1-yl)-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yl)-3-
methylbut-2-enoic acid (6)
4.1.18. (R,E)-5-((3aR,4R,7S,7aR)-7-((4R,5S,E)-5-
(Methoxymethoxy)-4-methylhex-2-en-1-yl)-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yl)-
2,2,3,3,6,10,10,11,11-nonamethyl-4,9-dioxa-3,10-disiladodec-6-ene
(37)
To a stirred solution of alcohol 38 (10 mg, 0.019 mmol) in a
mixture of CH3CN:H2O (1:1, 3 mL) were added BAIB (177.5 mg,
0.57 mmol) and TEMPO (5.6 mg, 0.04 mmol) at 0 ꢁC. The reaction
mixture was warmed to room temperature and stirred further for a
period of 2 h. The reaction mixture was passed through a short pad
of silica gel and the volatiles were removed under reduced pressure
to afford the crude residue. The residue was dissolved in CH2Cl2 and
the pH adjusted to 9 using saturated NaHCO3 solution. The layers
were separated and the aqueous layer was adjusted to pH ¼ 3e4
using aqueous 1N HCl. The acid was extracted with CH2Cl2
(3 ꢂ 5 mL), the combined extracts were washed with brine (6 mL),
dried over anhydrous Na2SO4, filtered and concentrated under
To a stirred solution of allylic alcohol 36 (44 mg, 0.083 mmol) in
CH2Cl2 (2 mL) cooled to ꢀ20 ꢁC were added 2,6 lutidine (22
mL,
0.19 mmol) followed by TBSOTf (20 mL, 0.09 mmol) and the reaction
mixture was stirred at the same temperature for 3 h. The reaction
mixture was then quenched with aqueous saturated NH4Cl solution
(1 mL) and the biphasic mixture was extracted with CH2Cl2
(2 ꢂ 2 mL). The combined organic layers were washed with brine
(4 mL), dried over anhydrous Na2SO4, filtered and concentrated
under reduced pressure to afford the crude product. Purification by
the flash column chromatography using 20% EtOAc/hexane (v/v) as
the eluent afforded compound 37 with dr 45:55 (43 mg,
reduced pressure to afford acid 6 (9 mg, 0.017 mmol) in 92% yield.
20
TLC: Rf ¼ 0.2 (ethyl acetate:hexanes, 6:4); [
a
]
D: þ29ꢁ (c 0.7,
CHCl3); IR (neat): 3447, 2927, 2857, 1691, 1617, 1315, 1059,
770 cmꢀ1
;
1H NMR (500 MHz, CDCl3):
d
6.05 (q, J ¼ 1.2 Hz, 1H),
0.067 mmol) in 81% yield. TLC: Rf ¼ 0.6 (ethyl acetate:hexanes, 4:6);
5.48e5.35 (m, 2H), 4.68 (d, J ¼ 6.9 Hz, 1H), 4.61 (d, J ¼ 6.9 Hz, 1H),
4.28e4.24 (m, 1H), 4.17 (dd, J ¼ 8.3, 5.1 Hz, 1H), 4.09 (dd, J ¼ 4.8,
2.0 Hz, 1H), 3.69 (dd, J ¼ 11.5, 2.7 Hz, 1H), 3.64e3.55 (m, 2H), 3.46
(dd, J ¼ 8.4, 2.4 Hz, 1H), 3.36 (s, 3H), 2.38e2.27 (m, 2H), 2.21e2.12
(m, 4H), 1.95e1.89 (m, 1H), 1.43 (s, 3H), 1.29 (s, 3H), 1.09 (d,
J ¼ 6.3 Hz, 3H), 1.00 (d, J ¼ 6.9 Hz, 3H), 0.93 (s, 9H), 0.07 (s, 3H), 0.03
(s, 3H); MS (ESI): 565 [MþNa]þ; HRMS (ESI): m/z Calcd. for
20
[
a]
D: þ1.1ꢁ (c 1, CHCl3); IR (neat): 2930, 2858, 1732, 1412, 1357,
1100 cmꢀ1; 1H NMR (500 MHz, CDCl3):
d
5.56 (tq, J ¼ 6.1, 1.2 Hz,1H),
5.46e5.35 (m, 2H), 4.67 (d, J ¼ 6.9 Hz, 1H), 4.60 (d, J ¼ 6.9 Hz, 1H),
4.23 (d, J ¼ 5.9 Hz, 2H), 4.15e4.08 (m, 2H), 4.05e4.02 (m, 1H), 3.63
(dd, J ¼ 11.4, 3.1 Hz,1H), 3.60e3.56 (m,1H), 3.54 (dd, J ¼ 11.4, 3.1 Hz,
1H), 3.46 (dd, J ¼ 7.6, 3.5 Hz, 1H), 3.36 (s, 3H), 2.34e2.24 (m, 1H),
2.20e2.07 (m, 2H), 1.93e1.85 (m, 1H), 1.62 (s, 3H), 1.45 (s, 3H), 1.31
(s, 3H), 1.08 (d, J ¼ 6.3 Hz, 3H), 0.99 (d, J ¼ 6.9 Hz, 3H), 0.90 (s, 9H),
0.89 (s, 9H), 0.06 (s, 9H), 0.02 (S, 3 h); 13C NMR (125 MHz, CDCl3):
C28H50O8SiNa: 565.3167, found 565.3186.
d
135.2, 135.0, 127.8, 127.2, 108.1, 95.1, 80.1, 77.7, 76.6, 75.6, 69.8,
4.1.21. (S)-Ethyl 3-hydroxybutanoate (25)
65.4, 60.0, 55.3, 42.2, 37.1, 33.3, 28.3, 26.5, 25.9, 18.3, 16.9, 15.7,
13.1, ꢀ4.7, ꢀ4.9, ꢀ5.15, ꢀ5.2; MS (ESI): 665 [MþNa]þ; HRMS (ESI):
m/z Calcd. for C34H66O7Si2Na: 665.4239, found 665.4261.
A 100-mL, parr hydrogenation vessel was charged with Ethyl
acetoacetate (6.5 g, 50 mmol) and degassed Ethanol (70 mL). To this
mixture was added the in situ prepared [(S)-2,20 Bis(diphenyl-
phosphino)-1,1'-binaphthyl]ruthenium(II) complex (0.1 mol%,
43 mg, 0.05 mmol) in degassed Ethanol (5 mL) under an argon. The
hydrogenation vessel was attached to a hydrogen source and hy-
drogenation was carried out at 50 psig H2 and 80 ꢁC for 8 h. After
the reaction mixture was allowed to cool to room temperature, the
stop valve was opened, excess hydrogen was carefully bled off, and
the apparatus was disassembled. The resulting orange solution was
poured into a 250 mL, round-bottomed flask, and the hydrogena-
tion vessel was rinsed with dichloromethane (3 ꢂ 30 mL). The
solvent was removed by a rotary evaporator, and the residue was
distilled to give hydroxy ester 25 with er 93:7 (6.3 g, 47.5 mmol) in
95% yield (bp 72 ꢁC,12 mm Hg). TLC: Rf ¼ 0.3 (ethyl acetate: hexane,
4.1.19. (R,E)-4-((tert-Butyldimethylsilyl)oxy)-4-((3aR,4R,7S,7aR)-7-
((4R,5S,E)-5-(methoxymethoxy)-4-methylhex-2-en-1-yl)-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yl)-3-
methylbut-2-en-1-ol (38)
A solution of 37 (20 mg, 0.03 mmol) in anhydrous THF (1.5 mL)
cooled to 0 ꢁC was treated with a solution of HF-pyridine (ca ~70%
HF, 0.2 mL). The reaction was stirred at the same temperature for a
period of 3 h, at which time the reaction was diluted dropwise with
aqueous saturated NaHCO3 solution (1 mL) and warmed to room
temperature with stirring. The reaction mixture was extracted with
CH2Cl2 (3 ꢂ 2 mL). The combined organic layers were washed with
brine (3 mL), dried over anhydrous Na2SO4, filtered and concen-
trated under reduced pressure to afford the crude product. Purifi-
cation by the flash column chromatography using 30% EtOAc/
hexane (v/v) as the eluent afforded compound 38 (12 mg,
30:70); [
a
]
25D ¼ þ38ꢁ (c ¼ 1.0, CHCl3); IR (neat) nmax: 3449, 2979,
ꢀ1
2938, 1732, 1377, 1188 cm
;
1H NMR (500 MHz, CDCl3):
d
4.18e4.10 (m, 3H), 2.94e2.68 (bs, OH), 2.43 (dd, J ¼ 16.8, 4.0 Hz,
1H), 2.37 (dd, J ¼ 16.8, 8.9 Hz, 1H), 1.27 (t, J ¼ 6.9 Hz, 3H), 1.20 (d,
0.023 mmol) in 77% yield. TLC: Rf ¼ 0.3 (ethyl acetate:hexanes, 4:6);
J ¼ 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3):
d 172.6, 64.1, 60.5, 42.8,
20
[
a]
D: þ17ꢁ (c 2.3, CHCl3); IR (neat): 3416, 2927, 2857, 1731,1487,
22.3, 14.0; MS (ESI): 133 [MþH]þ; HRMS (ESI): m/z Calcd. for
1335, 1059, 770 cmꢀ1; 1H NMR (500 MHz, CDCl3):
d
5.83e5.69 (m,
C6H13O3: 133.0859, found 133.0860.
Please cite this article in press as: Raghavan S, Ravi A, Synthesis of an advanced intermediate enroute to thiomarinol antibiotics, Tetrahedron